Collagen Solutions PLC (LON:COS)

Collagen Solutions PLC (LON:COS)


Share Price
4.00 p
Change
0.1 (2.56 %)
Market Cap
£17.75 m
Proactive Investors - Run By Investors For Investors

Collagen Solutions PLC RNS Release

Notice of Results


RNS Number : 1354C
Collagen Solutions PLC
13 June 2019
 

 

 

Collagen Solutions Plc

(the "Company")

 

Notice of Results

 

Analyst and Investor Briefing

 

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that it will issue its audited full year results for the year ended 31 March 2019 on Tuesday 9 July 2019.

 

Analyst briefing

An analyst briefing will take place at the offices of Walbrook PR, 4 Lombard Street, London, EC3V 9HD at 9.30am on Tuesday 9 July 2019.

 

Investor briefing

The Company will also be hosting an afternoon presentation for investors on Tuesday 9 July 2019, where Jamal Rushdy, CEO, and Hilary Spence, CFO, will summarise the full year results and discuss:

·    The Company and its operations;

·    Underlying business trends;

·    Growth strategy;

·    The recent placing and open offer;

·    Outlook and key milestones.

 

This investor event will take place at the Copper Bar, upstairs at Balls Brothers, 6 Adams Court, Old Broad St, London, EC2N 1DX at 4.30pm for a 4.45pm start. This will be followed by drinks and canapes, and a chance to network.

 

If you would like to register for either the analyst or investor presentation, please contact Walbrook PR on 020 7933 8780 or email [email protected] 

 

 

Enquiries: 

 

Collagen Solutions Plc

Contact via Walbrook

Jamal Rushdy, CEO         

 

Hilary Spence, CFO

 

 

 

Cenkos Securities plc (Nominated Adviser and Broker)

Giles Balleny / Stephen Keys

Tel: 0207 397 8900

 

 

 

Walbrook PR Ltd

    Tel: 020 7933 8780 or [email protected]

Anna Dunphy

Mob: 07876 741 001

       

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NORSFSFDDFUSEEM

Collagen Solutions PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use